These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17373337)

  • 1. Importance of renal function on prognostic value of cardiac iodine-123 metaiodobenzylguanidine scintigraphy.
    Furuhashi T; Moroi M
    Ann Nucl Med; 2007 Jan; 21(1):57-63. PubMed ID: 17373337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
    Narita M; Kurihara T
    J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
    Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K
    J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal dysfunction does not affect the prognostic value of myocardial iodine-123 meta-iodobenzylguanidine imaging in heart failure.
    Malhotra S; Wang L; Bunker CH; Winger D; Soman P
    Nucl Med Commun; 2014 Jan; 35(1):58-63. PubMed ID: 24177039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prognostic stratification by a combination of (123)I-metaiodobenzylguanidine scintigraphy and ejection fraction in dilated cardiomyopathy.
    Momose M; Okayama D; Nagamatsu H; Kondo C; Hagiwara N; Sakai S
    Ann Nucl Med; 2011 Jul; 25(6):419-24. PubMed ID: 21461599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-123 metaiodobenzylguanidine imaging can predict future cardiac events in Japanese patients with Parkinson's disease.
    Kinbara T; Hayano T; Otani N; Furutani Y; Tanaka S
    Ann Nucl Med; 2013 Feb; 27(2):123-31. PubMed ID: 23086545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy.
    Momose M; Kobayashi H; Iguchi N; Matsuda N; Sakomura Y; Kasanuki H; Kusakabe K; Okawa T
    Nucl Med Commun; 1999 Jun; 20(6):529-35. PubMed ID: 10451865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal iodine
    Okabe Y; Murai H; Tokuhisa H; Hamaoka T; Mukai Y; Sugimoto H; Takashima SI; Kato T; Matsuo S; Usui S; Furusho H; Takamura M; Kaneko S
    Auton Neurosci; 2020 Jul; 226():102671. PubMed ID: 32272358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
    Yamada T; Shimonagata T; Fukunami M; Kumagai K; Ogita H; Hirata A; Asai M; Makino N; Kioka H; Kusuoka H; Hori M; Hoki N
    J Am Coll Cardiol; 2003 Jan; 41(2):231-8. PubMed ID: 12535815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts.
    Nakata T; Miyamoto K; Doi A; Sasao H; Wakabayashi T; Kobayashi H; Tsuchihashi K; Shimamoto K
    J Nucl Cardiol; 1998; 5(6):579-90. PubMed ID: 9869480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.
    Imamura Y; Fukuyama T
    Ann Nucl Med; 2002 Sep; 16(6):387-93. PubMed ID: 12416577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
    Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
    J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Cardiac
    Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Nakamura J; Kayama K; Kawahira M; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M
    JACC Cardiovasc Imaging; 2022 Apr; 15(4):655-668. PubMed ID: 34656490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myocardial adrenergic nerve activity in valvular diseases assessed by iodine-123-metaiodobenzylguanidine myocardial scintigraphy].
    Imamura Y; Fukuyama T
    J Cardiol; 1997; 29 Suppl 2():21-6. PubMed ID: 9211099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.
    Kamiyoshi Y; Yazaki Y; Urushibata K; Koizumu T; Kasai H; Izawa A; Kinoshita O; Hongo M; Ikeda U
    Am J Cardiol; 2008 May; 101(10):1482-6. PubMed ID: 18471462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of cardiac (123)I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease.
    Ebina T; Takahashi N; Mitani I; Sumita S; Ishigami T; Ashino K; Minamisawa K; Kuji N; Ochiai H; Ishikawa Y; Oka T; Inoue T; Matsubara S; Umemura S
    Nucl Med Commun; 2002 Aug; 23(8):795-801. PubMed ID: 12124486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis.
    Cohen-Solal A; Esanu Y; Logeart D; Pessione F; Dubois C; Dreyfus G; Gourgon R; Merlet P
    J Am Coll Cardiol; 1999 Mar; 33(3):759-66. PubMed ID: 10080478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
    Merlet P; Valette H; Dubois-Randé JL; Moyse D; Duboc D; Dove P; Bourguignon MH; Benvenuti C; Duval AM; Agostini D
    J Nucl Med; 1992 Apr; 33(4):471-7. PubMed ID: 1552326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.